B-121 Evaluation of the use of Serum Amyloid A (SAA) as a diagnostic biomarker in prostate cancer
Prostate cancer (PCa) is a major health challenge in men and has contributed to a high rate of cancer-related death worldwide. Many risk factors for PCa are primarily related to age, family history, and ethnicity, but recent literature suggests that inflammation plays an active role in PCa development. Serum amyl...